[1]
A. Khare, V. Mandloi, A. Shrivastava, A. K. Shrivastava, P. Wadagbalkar, and A. Kumar, “Impact of oral palonosetron in improving quality of life as compared to other oral 5-HT3 antagonists in delayed chemotherapy induced nausea and vomiting in patients of head and neck cancer”, Int J Basic Clin Pharmacol, vol. 8, no. 3, pp. 493–496, Feb. 2019.